InvestorsHub Logo
Followers 19
Posts 1896
Boards Moderated 0
Alias Born 02/10/2014

Re: jbem777 post# 10853

Wednesday, 07/29/2015 12:09:12 PM

Wednesday, July 29, 2015 12:09:12 PM

Post# of 23979
Yes. The only way this might be a hell of a play is if the FDA accepts the secondary end points as the criteria for the registration trial---just like TNXP for fibromyalgia. Other than that, it's toast.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.